Investigation of vancomycin and high-level aminoglycoside resistant Enterococcus carriage and the risk factors related to resistance in hospitalized patients;Yatan hastalarda vankomisin ve yüksek düzey aminoglikozid dirençli enterokok taşιyιcιlιǧιnιn ve direnç ile ilişkili risk faktörlerinin araştιrιlmasι

Mikrobiyoloji Bulteni

Volumn 41, Issue 2, 2007, Pages 271-277

  Yildirim, Mustafa ^a   Şencan, Irfan ^b   Özdemir, Davut ^a   Öksüz, Şükrü ^c   Yilmaz, Zeynep ^d   Şahin, Idris ^a  

^a Yogun Bak m Section   (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c Sa lik Bakanli i Düzce Atatürk Devlet Hastanesi   (Turkey)

^d Bilecik Bozüyük State Hospital   (Turkey)

Author keywords

Antibiotic resistance; Colonization; Enterococcus; Risk factors

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG EFFECT; ENTEROCOCCUS; FECES; FEMALE; HETEROZYGOTE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; RISK FACTOR; TURKEY (REPUBLIC);

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; TURKEY; VANCOMYCIN RESISTANCE;

EID: 38549164895     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Moellering RC Jr. Enterococcus species, Streptococcus bovis and Leuconostoc species, pp: 2411-21. In: Mandell GIL, Bennett JE, Dolin R (eds), Principles and Practice of Infectious Diseases. 2005, 6th ed. Churchill Livingstone, New York.
2. Yüce A, Karaman M, Gülay Z, Yuluǧ N. Yenidoǧanlarda vankomisin dirençli enterokoklarin fekal taşiyiciliǧi. Ankem Derg 1999; 13: 7-11.
3. Teixeira LA, Facklam RR. Enterococcus, pp: 422-33. In: Murray PR, Baron EJ. Pfaller MA, Tenover FC, Yolken RH (eds), Manual of Clinical Microbiology. 2003, 8th ed. ASM Press, Washington.
4. Clinical and Laboratory Standards Institute Document. Antimikrobik Duyarlilik Testleri için Uygulama Standartlari (Çeviri). 2005, 15. Bilgi Eki. Döküman M100-S15. Türk Mikrobiyoloji Cemiyeti Yayini, Ankara.
5. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280-5.
6. Marcus N, Peled N, Yagupsky P. Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in Southern Israel. Eur J Clin Microbiol Infect Dis 1997; 16: 913-5.
7. Gökahmetoǧlu S, Sümerkan B, Eşel D, Karagöz S. Kan kültürlerinden izole edilen enterokok suşlarinin vankomisin ve yüksek düzey aminoglikozid dirençlerinin araştirilmasi. Ankem Derg 1999; 13: 57-62.
8. Suppola JP, Volin L, Valtonen VV, Vaara M. Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies. Clin Infect Dis 1996; 23: 694-7.
9. Gordon S, Swenson JM, Hill BC, et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. J Clin Microbiol 1992; 30: 2373-8.
10. Louie M, Simor AE, Szeto S, Patel M, Kreiswirth B, Low DE. Susceptibility testing of clinical isolates of Enterococcus faecium and Enterococcus faecalis. J Clin Microbiol 1992; 30: 41-5.
11. Vural T, Şekercioǧlu AO, Öǧünç D ve ark. Vankomisine dirençli Enterococcus casseliflavus suşu. Ankem Derg 1998; 12: 113.
12. Ertek M, Yazgi H, Aktaş AE, Erol S, Taşyaran MA. Vankomisin dirençli enterokok kolonizasyonu araştirilmasi ve diǧer antimikrobiyallere duyarliliklan. Infeks Derg 2003; 17: 447-51.
13. Çaylan R, Üstünakin M, Kadimov V, Aydin K, Köksal I. Fekal ve klinik örneklerden izole edilen enterokok suşlarinin antibiyotiklere duyadiliklari. Türk Mikrobiyol Cem Derg 2004; 34: 24-8.
14. Çinar T, Leblebicioǧlu H, Sünbül M, Eroǧlu C, Esen Ş, Günaydin M. Enterokoklarda yüksek düzey gentamisin ve streptornisin direncinin araştirilmasi. Flora 1999; 4: 114-9.
15. Töreci K, Öngen B. Antibiotic resistance in enterococci isolated from urine with emphasis to high-level resistance to beta-lactams and aminoglycosides. Ankem Derg 1993; 7: 217-24.
16. Moaddab SR, Töreci K. Enterokok suşlarinda antibiyotik direnci. Ankem Derg 1999; 13: 104.
17. Vandamme P, Vercauteren E, Lammens C, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572-6.
18. Ulusoy S, Hoşgör M, Özkan F, Özinel MA, Tokbaş A. Enterococcus faecalis ve Enterococcus faecium'un antibiyotik direncinin araştirilmasi. Ankem Derg 1995; 9: 12-6.
19. Hoşgör M, Ulusoy S, Özinel MA, Tünger A, Tokbaş A. Aminoglikozitlere yüksek düzeyde direnç gösteren enterokoklarin deǧişik antibiyotiklere karşi duyarliliklarinin araştirilmasi. Infeks Derg 1994; 8: 115-7.
20. Coudron PE, Markowitz SM, Wong ES. Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 1992; 36: 1125-6.
21. Öztürk R, Eroǧlu C, Köksal F, Mert A, Aygün G. Enterokoklarda antibiyotiklere direnç ve yüksek düzeyde gentamisin direnci. Ankem Derg 1995; 9: 351-4.
22. Rubin LG, Tucci V, Cercenado E, Eliopoulus G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992; 13: 700-5.
23. Bonten MJ, Hayden MK, Nathan C, et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348: 1615-19.